Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Quanterix Corporation (QTRX : NSDQ)

• Company Description    Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. The company services include Simoa Accelerator Lab and custom assay development services. Quanterix Corporation is based in LEXINGTON, United States. Number of Employees: 471

• Price / Volume Information    Yesterday's Closing Price: $5.51 Daily Weekly Monthly 20 Day Moving Average: 730,566 shares Shares Outstanding: 49.95 (millions) Market Capitalization: $275.25 (millions) Beta: 1.13 52 Week High: $16.01 52 Week Low: $4.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.64% -17.98% 12 Week -1.61% -14.30% Year To Date -48.17% -51.59%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 900 MIDDLESEX TURNPIKE - BILLERICA,MA 01821 USA ph: 617-301-9400 fax: - ir@quanterix.com http://www.quanterix.com

• General Corporate Information    Officers Masoud Toloue - President and Chief Executive Officer Martin D. Madaus - Chairman Vandana Sriram - Chief Financial Officer William Donnelly - Director Jeffrey T. Elliott - Director Peer Information Quanterix Corporation (BJCT) Quanterix Corporation (CADMQ) Quanterix Corporation (APNO) Quanterix Corporation (UPDC) Quanterix Corporation (IMTIQ) Quanterix Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 74766Q101 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 49.95 Most Recent Split Date: (:1) Beta: 1.13 Market Capitalization: $275.25 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.48 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.63 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.68 Price/Cash Flow: - Price / Sales: 2.03 EPS Growth vs. Year Ago Period: -103.85% vs. Previous Quarter: -76.67% Sales Growth vs. Year Ago Period: -5.40% vs. Previous Quarter: -13.73% ROE 06/30/25 - - 03/31/25 - -15.07 12/31/24 - -11.68 ROA 06/30/25 - - 03/31/25 - -12.26 12/31/24 - -9.59 Current Ratio 06/30/25 - - 03/31/25 - 8.29 12/31/24 - 8.66 Quick Ratio 06/30/25 - - 03/31/25 - 7.53 12/31/24 - 7.88 Operating Margin 06/30/25 - - 03/31/25 - -36.82 12/31/24 - -28.76 Net Margin 06/30/25 - - 03/31/25 - -36.82 12/31/24 - -28.76 Pre-Tax Margin 06/30/25 - - 03/31/25 - -37.24 12/31/24 - -27.72 Book Value 06/30/25 - - 03/31/25 - 8.16 12/31/24 - 8.57 Inventory Turnover 06/30/25 - - 03/31/25 - 1.68 12/31/24 - 1.70 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©